Literature DB >> 26031668

Role of Leadership in Narrowing the Gap between Science and Practice: Improving Treatment Outcomes at the Systems Level.

Sy Atezaz Saeed1, Richard M Bloch, Stuart Silver.   

Abstract

It's been well documented that health care does not reliably transfer what we know from science into clinical practice. As a result, Americans do not always receive the care suggested by the scientific evidence. Despite the best intentions of a dedicated and skilled healthcare workforce, this can often lead to poor clinical outcomes. As research and technology rapidly advance, this gap between science and practice appears to be widening. There is an increasing public concern about a lack of access to appropriate treatment, pervasiveness of unsafe practices, and wasteful uses of precious health care resources leading to suboptimum treatment outcomes. Leadership has a critical role in creating and sustaining the environment that supports health services for individuals and populations that increase the likelihood of desired health outcomes and are consistent with current professional knowledge. Leadership has some responsibility to improve outcomes by insuring effective use of evidence-based treatment guidelines; measurement-based care; knowledge and skills management; care coordination; and information technologies. This paper addresses leadership issues in these components of a system's ability to improve treatment outcomes.

Mesh:

Year:  2015        PMID: 26031668     DOI: 10.1007/s11126-015-9372-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  28 in total

1.  Organizational process: a missing link between research and practice.

Authors:  R A Rosenheck
Journal:  Psychiatr Serv       Date:  2001-12       Impact factor: 3.084

2.  VA practice patterns and practice guidelines for treating posttraumatic stress disorder.

Authors:  Craig S Rosen; Helen C Chow; John F Finney; Mark A Greenbaum; Rudolf H Moos; Javaid I Sheikh; Jerome A Yesavage
Journal:  J Trauma Stress       Date:  2004-06

3.  Evidence-based practice implementation in Kansas.

Authors:  Charles A Rapp; Richard J Goscha; Linda S Carlson
Journal:  Community Ment Health J       Date:  2010-04-23

Review 4.  Assessing the value of existing recovery measures for routine use in Australian mental health services.

Authors:  Philip Burgess; Jane Pirkis; Tim Coombs; Alan Rosen
Journal:  Aust N Z J Psychiatry       Date:  2011-02-11       Impact factor: 5.744

5.  Using measurement-based care with patient involvement to improve outcomes in depression.

Authors:  Larry Culpepper; Madhukar H Trivedi
Journal:  Prim Care Companion CNS Disord       Date:  2013

6.  Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.

Authors:  Quang A Le; Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  J Clin Psychiatry       Date:  2014-03       Impact factor: 4.384

7.  Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

Authors:  A F Lehman; D M Steinwachs
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Monitoring depression treatment outcomes with the patient health questionnaire-9.

Authors:  Bernd Löwe; Jürgen Unützer; Christopher M Callahan; Anthony J Perkins; Kurt Kroenke
Journal:  Med Care       Date:  2004-12       Impact factor: 2.983

9.  Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.

Authors:  Norman Sussman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

10.  The impact of nonclinical factors on care use for patients with depression: a STAR*D report.

Authors:  T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; Stephen R Wisniewski; A John Rush
Journal:  CNS Neurosci Ther       Date:  2009-08-27       Impact factor: 5.243

View more
  1 in total

1.  Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach.

Authors:  Anu Vähäniemi; Maritta Välimäki; Virve Pekurinen; Minna Anttila; Tella Lantta
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-09       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.